论文部分内容阅读
放免分析法测定146例恶性血液病血清β_2微球蛋白(β_2M)明显增高,化疗未缓解组(含部分缓解)虽有下降,与治疗前相比无明显差异。完全缓解组β_2M 明显下降,与治疗前相比差异有显著性,对部分病例动态观察,进一步证实上述结果。提示血清β_2M 含量与恶性血液病病情转归密切相关。
Radioimmunoassay method for the determination of 146 cases of hematologic malignancies serum β 2 microglobulin (β 2 M) was significantly increased, chemotherapy did not ease the group (including partial remission) Although there is no significant difference compared with before treatment. Complete remission group β 2 M decreased significantly compared with before treatment was significant, some cases of dynamic observation, to further confirm the above results. The results suggest that serum β_2M levels are closely related to the prognosis of patients with hematologic malignancies.